Hi, gang. Been following this for some time and it's very good news, as the medication is proving helpful to patients here in the US.
RJ
Alkermes Submits Marketing Authorization Application for Vivitrol in the United Kingdom and Germany
Apr 2 2007, 8:00 AM EST
Business Wire
Alkermes, Inc. (Nasdaq: ALKS) today announced that the company has submitted a Marketing Authorization Application (MAA) for VIVITROL(R) (naltrexone for extended-release injectable suspension) to regulatory authorities in the United Kingdom (Medicines and Healthcare Products Regulatory Agency, or MHRA) and Germany (Bundesinstitut fur Arzneimittel und Medizinprodukte, or BfArM). VIVITROL, the first and only once-monthly treatment for alcohol dependence, was approved by the U.S. Food and Drug Administration (FDA) in April 2006.
Read more here.
RJ
Alkermes Submits Marketing Authorization Application for Vivitrol in the United Kingdom and Germany
Apr 2 2007, 8:00 AM EST
Business Wire
Alkermes, Inc. (Nasdaq: ALKS) today announced that the company has submitted a Marketing Authorization Application (MAA) for VIVITROL(R) (naltrexone for extended-release injectable suspension) to regulatory authorities in the United Kingdom (Medicines and Healthcare Products Regulatory Agency, or MHRA) and Germany (Bundesinstitut fur Arzneimittel und Medizinprodukte, or BfArM). VIVITROL, the first and only once-monthly treatment for alcohol dependence, was approved by the U.S. Food and Drug Administration (FDA) in April 2006.
Read more here.